Athletes, Opioids and the Athletic Therapist by Vandertuin, Jacqueline
















Athletes, Opioids and the Athletic Therapist 
 
  






Elite athletes are competitors and as a result they will naturally develop a “win at all cost” 
mentality.  This mentality can come from within or as a result of pressure from coaches, 
teammates and/or other key stakeholders.1  When asked of an injury, any elite athlete will 
share stories of how the injury impacted them physically and if probed, psychosocially as well.  
For elite athletes, their sport will often form their identity; removing the athlete from the sport 
will remove their core being.   
Elite athletes understand that pain is a part of the game.1  As the athlete progresses 
through their career, they will learn pain management techniques that will allow them to 
continue playing when injured and experiencing pain.  These management techniques are as 
multifaceted as the athletes themselves and may come directly from health care practitioners 
such as Athletic Therapists, and/or physicians or other non-health care sources such as 
teammates, coaches, or the internet.1,2  To support their pain management, athletes will often 
use either pharmacological and/or non-pharmacological techniques to assist them to silence 
their pain; to help them play at their highest level.  Pain and injury can impact performance and 
as a result, eliminating pain will help to mitigate its negative effects on athletic performance.  In 
an effort to quickly manage pain, elite athletes will commonly use prescription and over-the-
counter (OTC) analgesics to prevent or relieve pain.3,4  Pharmacological interventions typically 
used by athletes include oral and injectable non-steroidal anti-inflammatory drugs (NSAIDs), 
other non-opioid analgesics, opioid analgesics, injectable and transdermal anaesthetics and 
other medications and OTC supplements to manage their pain.3-7  Reports vary on the 
frequency of use of medications by athletes to alleviate pain, however, Harle et al., found that 
NSAIDs are the most commonly used pain medication with reports on prevalence from 2.4% 
detected in urine samples to 100% use in non-traumatic injuries.3  The differences in reported 
use may be attributed to differences in the sports studied (i.e. collision versus non-contact) as 
well as sex of the individual.8 
Opioids are a group of medications used to treat moderate to severe pain.5,9  These 
medications work by altering the way the brain and nervous system respond to pain.  
Generally, they come in tablets and may be crushed, snorted, chewed, or injected for a heroin-
like high. Although opioids are typically prescribed for the management of moderate to severe 
pain, research reports that many individuals will use opioids in a non-prescribed fashion.4,8,10   
Non prescribed opioid use in athletes has been reported to be as low as 1% to as high as 18% 
of collegiate athletes.3,5,11 





The purpose of this paper is to inform the reader of athlete’s use of pain-reliving 
medications, in particular the use of opioids.  This paper will discuss the opioid pandemic in 
general and relate that information directly to athletes.  It will discuss the history of opioid use, 
the role that the Athletic Therapist plays with regards to opioid use and misuse by athletes and 
provide recommendations to prevent an athlete’s misuse of opioids geared specifically to the 
Athletic Therapist, institutions and associations. 
The Opioid Pandemic 
 There is currently a hidden pandemic that is impacting all individuals in some way, 
whether it is direct or indirect. In the early 2000’s, headlines began to surface regarding 
overdoses and warnings of opioid misuse.   In 2015, something happened in the US that 
hasn’t happened since the influenza pandemic of 1918; life expectancy entered a period of 
sustained decline with the culprit being a surge in drug overdoses and suicides with both 
linked to opioids.12  News organizations were warning individuals about the growing numbers 
associated with opioid use with recent reports indicating that the current COVID-19 pandemic 
is flaming the fire of opioid overdoses.13  Current reports indicate that the current 
implementation of restrictions due to the COVID-19 pandemic is triggering increases in opioid 
overdoses.13   
 In June 2020, the chief coroner of Ontario announced a 25% increase in 
suspected drug related deaths with similar trends seen in other provinces.13  As reported in the 
Ontario Opioid Report and other research, opioid use is increasing as well as deaths due to 
overdoses particularly among the 25-44 year old population.13,14  The opioid pandemic is not 
new, and its roots can be traced back to the 1980’s when health care practitioners (namely 
physicians) began looking at pain management strategies more closely.  In 1995, the 
American Pain Society launched a campaign that framed pain as the “fifth vital sign” and 
indicated that pain should be monitored and managed in a similar fashion as other vital 
signs.12  Pharmaceutical companies dived into research investigating pharmacological options 
to manage pain and as a result, these companies began utilizing paid physicians to expound 
the safety and benefits of prescribing opioids; providing support that the prescription of  
opioids is the humane approach to pain management.15  Physicians became pressured to 
continue to prescribe these medications over using non-pharmacological treatments and were 
guilted into believing that allowing individuals to live with pain and not provide  
pharmacological management was both unethical and inhumane.15  As a result, 
pharmaceutical companies began expediting research into drugs which they marketed as 
optimal pain control with little or no addictive qualities.12,15  However, longer term studies soon 





discovered the exact opposite occurred and as a result found that these medications were in 
fact, highly addictive and that they were frequently misused.12,15  As a result, Pandora’s box 
had been opened, paving the way for the initial stage of the opioid pandemic.   
The opioid pandemic has highlighted cracks within the health care system in both the US 
and Canada.  In the US, due to doctors being part of private practice, physicians can benefit 
financially by increasing the volume of patients they see as well as ensuring patient 
satisfaction which can incentivize over prescription of pain medication.12  US insurance plans 
often cover pain medication, but not other pain management strategies such as physical 
therapy.12  Unfortunately, Canada is not immune and physicians are also paid by the number 
of patients seen which may help to explain why Canada is experiencing a similar crisis as the 
US with non-pharmacological options (such as Athletic Therapy) covered by private insurance 
plans only.  Since the time that opioids were introduced, overdoses have increased with 
research finding 66.4% of all current drug overdoses reported are due to opioids.14 
Opioids were originally prescribed for the management of cancer pain, but in the 1990’s 
researchers began to question why they weren’t used for the management of chronic pain and 
thus began the prescription of opioids for a multitude of conditions.15  Marginalized populations 
are at the greatest risk of opioid use, misuse and overdoses for a myriad of reasons.13  As a 
result of this information, stigma developed, painting individuals who misuse opioids as being 
part of marginalized populations only.16  Unfortunately, this portrayal is inaccurate and misuse 
and addictions are not isolated to marginalized populations but are seen in athletes often 
resulting from pain management strategies that arose from injuries or surgical 
procedures.3,17,18  Therefore, it is important to recognize that although marginalized 
populations may represent greater numbers of those addicted to opioids, athletes are not 
immune. 
Public response to the opioid crisis has been mixed, most likely due to the stigma 
attached to those who rely on opioids to manage their pain.  Athletes have frequently engaged 
in pain-relieving medication (PRM) to continue to play/practice which is often an accepted 
practice by those directly involved with athletes.3  In this culture of sport, athletes are 
frequently praised for their strength in being able to play after injury, however, athletes will 
often rely on medications to quash their pain to allow them to continue to play.  Research has 
demonstrated that athletes frequently begin use of PRM including opioids in adolescence, 
believing that their actions have few consequences other than allowing them to continue to 
play.1,4,11    





 The National Athletic Trainers Association (NATA) has responded to this concern with 
information posted on their public resource page to provide the public with links related to 
information on opioid abuse.19  NATA has recognized that the opioid pandemic has indeed 
effected the general public, but also impacts athletes.   Recent media sources have 
highlighted athletes and their use of opioids and other PRM as well as informing on the 
negative consequences associated with their use.20  The opioid pandemic is real and is not 
just found within the marginalized populations; it is found directly on the fields, clinics, and 
arenas that Athletic Therapists work at. 
In response to the current pandemic, governments are increasing resources and 
educational campaigns to mitigate the issues that have developed as a result.  Pharmaceutical 
companies have been strongly reprimanded with increases in the number of lawsuits brought 
against them.12,15  Government educational strategies have been developed to reign in the 
problems that have resulted.  Maintaining adequate pain control is still a priority, however, a 
refocus has begun including governmental/institutional policy changes in the US to meet the 
growing concerns surrounding opioid use with university/college institutions mandating policy 
changes and educational initiatives on the use of an overdose antidote, naloxone 
(Narcan™).13,21  However, the question remains; if many recognize that the opioid pandemic is 
real and athletes are not immune, what information is being relayed to Canadian athletes, 
Athletic Therapists (ATs) and other health care providers who work directly with athletes to 
protect their health? 
Athletes and PRM 
Athletes know the risk of playing a sport and understand that one of the risks is 
becoming injured which will result in experiencing pain.  The International Association of the 
Study of Pain (IASP) has recently updated their definition in 2019 to better reflect that pain 
carries an emotional component and is individualized.22  As a result, the IASP has defined pain 
as, “An aversive sensory and emotional experience typically caused by, or resembling that 
caused by, actual or potential tissue injury.”22  Therefore, pain is not just a biological event; it is 
multifaceted and is wrapped up in the psychological and sociological context which is situation 
dependent.9  To understand athletes’ pain, it is important that a complete picture of the athlete 
is presented and understood by the health care practitioner to best help an athlete manage 
their pain.9  Given the complexities associated with pain, it is often difficult to establish 
guidelines for pain management, especially considering that elite athletes often are unable to 
“take time off to heal” from their injuries. 





In comparison to the public, elite athletes will most likely experience pain differently.  
Elite athletes often have added pressures to continue to train and compete and as such may 
experience a heightened need to continue to play even though they are injured and currently 
experiencing pain.1  As a result, many athletes will engage in using PRM in an attempt to 
minimize pain in order to effectively play.1,3,11,23  Elite athletes often have access to a 
multidisciplinary team to assist in their health care management.  Unfortunately these health 
care providers report feeling tremendous pressure to assist athletes so they do not miss 
games due to injuries.3,16 As cited in Harle et al., health care practitioners have provided 
analgesics to athletes due to their personal guilt related to athletes missing matches, their fear 
of athletes losing a roster spot and a desire to assist athletes in reaching minimum game 
appearance thresholds to achieve additional pay.3  However, often those involved with 
athletes report feeling uneducated and uncomfortable discussing the misuse of opioids.16,24  
Therefore, athletes may be a higher risk to misuse PRM due to the lack of education of their 
therapists not to mention the personal guilt the therapist may feel to manage athletes’ pain. 
Youth athletes in contact and collision sports (i.e. wrestling, football and ice hockey) are 
at the greatest risk to engage in non-prescribed use of prescription opioids (NUPO) in 
comparison to non-participants or participants in other sports.4,6,8,10,11  Research reports that 
the greatest risk factors for opioid misuse are associated with males, who are under the age of 
20 and are involved in contact and collision sports. 10,17  Results from previous research has 
found those involved with NUPO had also higher rates of associated heroin use.4  It has often 
been touted that sport participation offers a protective effect against the use of recreational 
drugs however that protective effect may prevent the true picture from emerging.  If sport 
participation is broken into further categories of sex, type of sport and level of play, sport may 
heighten certain types of drug use; specifically, NUPO with the greatest risks associated with 
males, having an injury and playing varsity collision sports.4,6,7   McDuff et al., discovered in 
their comprehensive review that binge alcohol, oral tobacco, NUPO and anabolic-androgenic 
steroid use are higher among athletes especially in power and collision sports.11  Cottler et al., 
revealed that predicators of misuse in former National Football League (NFL) athletes related 
to moderate to significant pain, undiagnosed concussions (believing if they reported 
concussions, they would be pulled from play) and heavy drinking.25 
Unfortunately, NUPO can begin as early as adolescence.   As cited in Outlaw et al., 20% 
of student athletes will sustain an injury during play with just short of 50% requiring surgery 
and concurrent prescription of opioids as a form of a pain reliever.6 Bates wrote that 8.7% of 
12th graders indicated NUPO during the past year which was associated with a 33% increase 





in future opioid use after high school.24  Unpublished research has found that athletes trust 
their AT for advice related to  PRM and would take medication if recommended by their AT.1  
Research has revealed that athletes have very little knowledge when it comes to PRM and will 
often consult unreliable sources such as peers, internet and coaches for information if a health 
care practitioner is not available.1,2 
There are a multitude of reasons as to why an athlete would engage in NUPO, however, 
a prevailing theme is pain management.  Athletes are at a higher risk of experiencing pain due 
to injury when compared to less active populations; with this problem of pain in athletes 
persisting even after retirement. Reports indicate that approximately 15% of NFL players 
suffered an injury within 2 weeks of beginning play with 68% injured in any given year.25  
Research has unveiled that almost half of retired NFL players have used opioids during their 
careers and that within a surveyed group, almost 70% have reported opioid misuse.25,26  
Therefore, the long term implications of injury may be related to the continuation of opioid use 
and impact the athlete’s ability to continue to earn a wage and have a good quality of life.26  
Studies have reported that physicians will often write prescriptions for more pain medication 
than used by patients with patients routinely not knowing how to properly dispose of such 
medication.27 Anterior cruciate ligament reconstructions (ACLR) are one of the most frequently 
preformed surgeries of athletes with increasing rates of tears seen in the adolescent 
population.  Research has found that the largest number of individuals undergoing ACLR are 
under 20 years of age with 25.5% of all patients having a preoperative opioid prescription.17  
These numbers are concerning considering that previous opioid prescription increases the risk 
for future NUPO use.28  Overwhelmingly, most athletes will receive opioid prescriptions from 
physicians for pain management of injuries, however, research has found that athletes will 
engage in NUPO of the same prescription for other injuries and/or will divert their prescription 
to other athletes who request their use.1,10 
Opioid physical dependence develops quickly.  Opioids are prescribed for the 
management of pain especially post-operative pain.  As with any medication, side effects such 
as constipation are common, however, what is more concerning to the health care 
practitioners are the role that opioids play in decreasing cognitive function as well as impair 
judgement not to mention their highly addictive qualities.29  These effects are especially 
pronounced during the first few days of using an opioid, before tolerance develops.29  
Ultimately impairments of cognitive functioning will impact the athletes ability to make 
appropriate judgements, potentially increasing the likelihood of injury.  As well, given that the 
medication will diminish cognitive abilities as well as pain, ATs will not be able to appropriately 





recognize injury and injury severity due to the lack of pain experienced by the athlete.  To 
heighten the reality of the situation with elite athletes, research has found that  81% of NFL 
athletes with undiagnosed concussions were strongly associated with opioid misuse.25  The 
authors of this study speculated that these athletes did not want to be pulled from play and 
therefore chose to manage their pain on their own.25  As a result, ATs may inadvertently deem 
an athlete fit to play; even though the athlete may be suffering significant injuries such as 
concussions.  
Many athletes have reported resorting to Tramadol to decrease pain perception as well 
as the touted less addictive properties offered by this medication.30  Although the World Anti-
Doping Association (WADA) prohibits opioid use, the benefit of Tramadol is that it is not 
currently banned by WADA.30  However, Tramadol use is not without issues: use of Tramadol 
has been found to produce several drawbacks including dizziness, loss of alertness, 
drowsiness and physical dependency which could affect the safety of the athlete.30  As seen in 
the TNS documentary, The Problem of Pain, Rick Westhead discussed how hockey players 
were provided medication in an order to continue to play.  He described in his film how 
athletes are venerated for their “toughness” and “strength of character” when they are able to 
play through pain highlighting  how these athletes feel the pressure to play in order to keep 
their spot on the roster.31 Although, the medication Torodol is not an opioid, the use of this 
medication is for short term usage (recommendation is that it is not to be taken for longer than 
5 days) with misuse linked to many complications.31  In this documentary, retired National 
Hockey League hockey player Ryan Kesler reported regularly using anti-inflammatories as 
well as Torodol when the pain was too severe.31  Kesler also reports that his current colitis is a 
result of Torodol use which has lead to lifelong disabilities.31    
Opioid use in professional sport is not new and the consequences of such use can be 
severe.  In 2011, Derek Boogaard (28 years age) died from mixing alcohol with the opioid 
Oxycodone.  The New York Times reported Boogaard received large amounts of prescription 
drugs from team doctors before and after his entry into the league’s substance abuse program 
with an ex hockey player eventually charged with selling him pills leading to his untimely 
death.32  Professional hockey and football are not alone with regards to professional athletes 
and addiction/overdose issues.  Professional athletes who’ve died as a result of misuse of 
prescription medication includes but is not limited to:  Erica Blasberg, golfer aged 25; Scott 
Charles “Bam, Bam” Bigelow, professional wrestler aged 45; Christopher Wiley Antley, horse 
racing aged 34.   
 





State of pain management in elite athletes 
Athletic Therapists have a wide and varied approach to the management of pain using 
non-pharmacological options.  Providing medications to athletes is not within the purview of an 
AT, however, knowledge of medications and their interactions will assist the AT to provide a 
comprehensive management plan for their athletes to prevent and manage injuries.  Although, 
ATs have a vast arsenal of non-pharmacological options to manage pain, many teams provide 
carte blanche to the AT to provide medications to their athletes.16  As such, ATs should be well 
informed of medications, however, research has found that they report a lack sufficient 
knowledge to be able to recognize and counsel athletes with regards to pharmacological 
options.16,24  
In 2016, a group was struck by the International Olympic Committee (IOC) to provide 
guidelines for the management of pain in elite athletes.5  Prior to this paper, there was a lack 
of evidence based or consensus-based guidelines that health care providers could refer to.  
The IOC guidelines highlighted that non-pharmacological pain management should be 
considered in the earliest stages of pain and beyond.5  Factoring into the management was an 
emphasis on individualizing the treatment options; adopting an approach that focused not 
solely on the biological indications of pain, but also the psychosocial and other contextual 
factors.5  The IOC emphasized the importance of education to better help individuals 
understand their options for pain management.5,9  Research has demonstrated that education 
can allow individuals of all ages to make better decisions regarding their health care 
management.33  Concerning the IOCs recommendations for prescription opioids, indications 
were provided that opioids should only be provided if the athlete was experiencing severe pain 
with the initial prescription not exceeding 5 days and no opioid prescription given beyond 10 
days.5  Unfortunately, routine prescriptions for longer than 10 days have been reported in the 
literature with many individuals having left over prescriptions.17,18 
The role of the Athletic Therapist 
Athletic Therapists wear many hats with their roles being targeted under the domains of 
prevention, assessment, intervention, practice management, and professional responsibility as 
reflected in the scope of practice of an Athletic Therapist. 34  This scope of practice states that 
Certified Athletic Therapists “…in cooperation with performance enhancement personnel and 
members of the health care delivery team, is an integral part of a total service to maximize the 
performance and welfare of all Canadians. Concomitant with the execution of this role, the 
Athletic Therapist nurtures an attitude of positive health.” As such, this can be interpreted that 
the AT must be aware of all aspects of an athlete’s health and work as part of a 





multidisciplinary team to prevent and manage situations including the use/misuse of 
medications.    
Pharmacology courses are embedded within Athletic Therapy curriculum either as a 
stand-alone course or as a module within curriculum at accredited Athletic Therapy programs 
in Canada.  It is unknown the extent to which curriculum instructs on PRM particularly opioids.  
The research makes it clear that athletes are engaging in PRM including opioids and are often 
misusing them to prevent or manage their pain.  As a result of this and the impact on an 
athlete’s health, ATs should be aware of the effects and consequences of such medication to 
abide by their scope of practice and protect the athlete from harm.  American data provides an 
indication that both high school and collegiate level athletes use opioids and as such a greater 
emphasis has been provided to Athletic Trainers on the recognition and management of 
athletes NUPO with public resources provided on opioid abuse on the NATA website.19   
In 2020, Bates conducted a qualitative study to investigate Athletic Trainers’ awareness 
of opioids.  This study highlighted 3 common themes among participants; 1) Athletic Trainers 
felt a responsibility to educate patients regarding opioids; 2) Athletic Trainers must 
communicate to patients about opioids and; 3) Athletic Trainers perceived they lacked 
education with regards to opioids.24  Many authors have discussed the need for a 
multidisciplinary approach that incorporates effective prevention and intervention programs for 
athletes with authors advocating for policy changes at the school/team level. 6,21,27,35  Research 
has found that preoperative filling of opioid prescriptions and a lack of education regarding 
disposing of opioids as a strong risk factor for continual opioid use.18,28 As cited in Merrill et al., 
opioid misuse can begin at an early age, with an average age of first use at 12.6 years.18 Many 
elementary and middle schools have Drug Abuse Resistance Education (D.A.R.E.) programs 
within their curriculum that are offered throughout all years, however, many schools only offer 
core curriculum and do not provide enhanced programs that focus on opioids and OTC 
medications. Implementing these programs are critical to educating students and athletes on 
PRM so they may be accountable and advocate for their health.  Adding drug awareness 
programs (including PRM, opioids and alcohol) at the collegiate level will also create an 
awareness and enhance knowledge so athletes can be informed of the benefits and 
drawbacks of PRM use.  It would be prudent for governing athletic associations or institutions 
with athletic teams to look at their current policies regarding the management of medications 
and institute educational champaigns to athletes with regards to medications.  In 2018, NATA 
released a position statement on the management of medications by the sports medicine 
team.36  The authors of this position statement differentiated the roles that physicians and 





Athletic Trainers play with regards to administering and dispensing medications.36 Information 
was provided on various types of medication including OTC medications, prescription 
medications, as well as suggestions on judicious use of opioids and reliance on non-addictive 
drugs such as NSAIDs to manage pain.36 Within those guidelines, recommendations were 
provided in that Athletic Trainers are required to act as a resource for questions or answer 
athletes concerns regarding medication as well as possessing a working knowledge of OTC 
medications.36 Arming health care providers such as ATs with information related to PRM, 
especially opioids, can ultimately assist athletes and the general public to make informed 
decisions regarding their personal PRM use.9     
Conclusion 
We are currently experiencing an opioid pandemic with overdoses occurring with much 
greater regularity among the general population with our athletes not being immune to this.  
Currently, there is no known research regarding athletes and how they are faring during this 
current COVID and opioid pandemic.  Athlete opioid addictions and deaths due to overdoses 
is not unheard of and must be addressed. ATs are the eyes and ears within the athletic 
environment with their role incorporating not just assessment and management of injuries, but 
prevention of injuries, including recognition of medication use and misuse.  Education is a key 
force in mitigating the effects of the opioid pandemic and that education should be directed to 
all personnel associated with teams.  ATs who are responsible for pain management need to 
work in collaboration with other health care providers.9   Implementing policies by athletic 
teams, the Canadian Athletic Therapists Association (CATA) and its provincial associations as 
well as at institutional levels to prevent ambiguity among key stakeholders with regards to 
medication management can prevent guilt and distress among ATs. As such, this author is in 
complete agreement with Leone et al., in that ATs need to have a working knowledge of how 
analgesics are used to treat pain, understand their common side effects and have readily 
available interventions for the misuse of prescribed medications.21  It is imperative that 
continuing education of ATs and other health care professionals be mandated in the field of 
medication in particular related to PRM.9  Providing Athletic Therapists opportunities to learn 
about PRM will have a trickle down effect with information passed from the AT to the 
athletes/coaches and other key stakeholders, especially considering most athletes gain much 
of their knowledge from internet sources, peers, teammates and members of the coaching 
staff.1,2  This is an opportunity for CATA to delve deeper into the complexities associated with 
pain management, be a leader in Canada and mirror their NATA counterparts.  Misuse of 





medication has been a problem for a significant amount of time; now is the time to address it 
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